People · Operator
Named in public records as an officer, director or promoter · active 2021–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| LianBio | — | Pharmaceuticals | Series D+ | $273.0M | $85.3M | 2021 |
TOM ANASTASIOS GIANNAKAKOS at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside TOM ANASTASIOS GIANNAKAKOS on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Konstantin Poukalov | 1 | 5 |
| DEBRA ANASTASIOS YU | 1 | 1 |
| NEIL LEO KUMAR | 1 | 1 |
| ADAM LEO STONE | 1 | 1 |
| BING LEO LI | 1 | 1 |
| TASSOS LEO GIANAKAKOS | 1 | 1 |
| DEBRA LEO YU | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.